Trial Profile
Clinical Evaluation of BW430C in Epilepsy<Phase III Study>.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Jul 2023
Price :
$35
*
At a glance
- Drugs Lamotrigine (Primary)
- Indications Epilepsy; Generalised seizures; Lennox-Gastaut syndrome; Partial epilepsies; Tonic-clonic epilepsy
- Focus Adverse reactions; Registrational
- Sponsors GlaxoSmithKline; GSK
- 25 Jul 2009 New trial record